PROFILE COMMISSION |
|
E.M. Shilov, O.N. Kotenko, M.M. Shilova, K.S. Milchakov, E.I. Rumyantseva, R.A. Khalfin
Epidemiology of COVID-19 in patients receiving renal replacement therapy in the Russian Federation: results of 2020
|
5-12 |
O.N. Kotenko, N.V. Vasina, L.V. Marchenkova, M.A. Lysenko
State of renal replacement therapy for chronic kidney disease in Moscow in 2015–2020
|
13-19 |
WORLD KIDNEY DAY |
|
Kamyar Kalantar-Zadeh, Philip Kam-Tao Li, Ekamol Tantisattamo, Latha Kumaraswami, Vassilios Liakopoulos, Siu-Fai Lui, Ifeoma Ulasi, Sharon Andreoli, Alessandro Balducci, Sophie Dupuis, Tess Harris, Anne Hradsky, Richard Knight, Sajay Kumar, Maggie Ng, Alice Poidevin, Gamal Saadi, and Allison Tong
Living well with kidney disease by patient and care-partner empowerment: kidney health for everyone everywhere
|
20-26 |
CLINICAL GUIDELINES |
|
M.Z. Gasanov, M.M. Batyushin, A.S. Litvinov, V.P. Terentyev
Covid-19-associated acute kidney injury: consensus report of the 25TH ACUTE DISEASE quality initiative (ADQI) workgroup: translation of recommendations
|
27-49 |
ORIGINAL PAPERS |
|
Z.D. Mikhailova, D.V. Pivovarov, S.M. Rumyantseva, A.R. Pivovarova
KIM-1 as the biomarker of acute kidney injury in patients with the acute coronary syndrome and oncological diseases
|
50-55 |
I.T. Murkamilov, I.S. Sabirov, V.V. Fomin, Zh.A. Murkamilova, I.O. Kudaibergenova, F.A. Yusupov
Relationship between tumor necrosis factor alpha and interleukin-10 and left ventricular remodeling in renal failure
|
56-62 |
LITERATURE REVIEWS |
|
Sh. S.Abdullaev, R.Sh. Igamberdiyeva, O.N. Sharapov
Kidney damage in Covid-19: clinical-pathogenetic aspects and management of patients with chronic kidney disease
|
63-67 |
A.V. Malinovsky
Histidine in healthy people and patients with uremia
|
68-71 |